4processed

Form 4 — Insider Transaction

Theravance Biopharma, Inc.(TBPH)

Filing Date

May 20, 2026

Accepted

May 20, 2026

Accession No.

0001961289-26-000006

CIK

0001583107

Insider Transactions

InsiderTitleTypeSharesPriceValueOwned AfterSecurityDate
Sawaf AzizSVP & CHIEF FINANCIAL OFFICEROther8.7K$16.55345.0KOrdinary SharesMay 20, 2026